These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31671889)

  • 1. Modulation of Calretinin Expression in Human Mesothelioma Cells Reveals the Implication of the FAK and Wnt Signaling Pathways in Conferring Chemoresistance towards Cisplatin.
    Wörthmüller J; Salicio V; Oberson A; Blum W; Schwaller B
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of calretinin in malignant mesothelioma is mediated by septin 7 binding to the CALB2 promoter.
    Blum W; Pecze L; Rodriguez JW; Steinauer M; Schwaller B
    BMC Cancer; 2018 Apr; 18(1):475. PubMed ID: 29699512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calretinin Functions in Malignant Mesothelioma Cells Cannot Be Replaced by the Closely Related Ca
    Wörthmüller J; Oberson A; Salicio V; Blum W; Schwaller B
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30545133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem Cell Factor-Based Identification and Functional Properties of In Vitro-Selected Subpopulations of Malignant Mesothelioma Cells.
    Blum W; Pecze L; Felley-Bosco E; Wu L; de Perrot M; Schwaller B
    Stem Cell Reports; 2017 Apr; 8(4):1005-1017. PubMed ID: 28285878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCL9 promotes epithelial mesenchymal transition and invasion in cisplatin resistant NSCLC cells via β-catenin pathway.
    Zhang Y; Zhang Q; Chen H; Wang C
    Life Sci; 2018 Sep; 208():284-294. PubMed ID: 30009824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of disheveled-2 resensitizes cisplatin-resistant lung cancer cells through down-regulating Wnt/β-catenin signaling.
    Luo K; Gu X; Liu J; Zeng G; Peng L; Huang H; Jiang M; Yang P; Li M; Yang Y; Wang Y; Peng Q; Zhu L; Zhang K
    Exp Cell Res; 2016 Sep; 347(1):105-113. PubMed ID: 27432651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urokinase-type plasminogen activator receptor promotes proliferation and invasion with reduced cisplatin sensitivity in malignant mesothelioma.
    Wang S; Jiang L; Han Y; Chew SH; Ohara Y; Akatsuka S; Weng L; Kawaguchi K; Fukui T; Sekido Y; Yokoi K; Toyokuni S
    Oncotarget; 2016 Oct; 7(43):69565-69578. PubMed ID: 27602956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway.
    Xie SL; Fan S; Zhang SY; Chen WX; Li QX; Pan GK; Zhang HQ; Wang WW; Weng B; Zhang Z; Li JS; Lin ZY
    Int J Cancer; 2018 Mar; 142(6):1252-1265. PubMed ID: 29071717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression or absence of calretinin in mouse primary mesothelial cells inversely affects proliferation and cell migration.
    Blum W; Pecze L; Felley-Bosco E; Schwaller B
    Respir Res; 2015 Dec; 16():153. PubMed ID: 26695618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia promotes acquisition of aggressive phenotypes in human malignant mesothelioma.
    Kim MC; Hwang SH; Kim NY; Lee HS; Ji S; Yang Y; Kim Y
    BMC Cancer; 2018 Aug; 18(1):819. PubMed ID: 30111297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocrine CSF-1R signaling drives mesothelioma chemoresistance via AKT activation.
    Cioce M; Canino C; Goparaju C; Yang H; Carbone M; Pass HI
    Cell Death Dis; 2014 Apr; 5(4):e1167. PubMed ID: 24722292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of Meg3 enhances cisplatin resistance of lung cancer cells through activation of the WNT/β-catenin signaling pathway.
    Xia Y; He Z; Liu B; Wang P; Chen Y
    Mol Med Rep; 2015 Sep; 12(3):4530-4537. PubMed ID: 26059239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro.
    You M; Varona-Santos J; Singh S; Robbins DJ; Savaraj N; Nguyen DM
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):508-16. PubMed ID: 24094913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt/IL-1β/IL-8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5.
    Milosevic V; Kopecka J; Salaroglio IC; Libener R; Napoli F; Izzo S; Orecchia S; Ananthanarayanan P; Bironzo P; Grosso F; Tabbò F; Comunanza V; Alexa-Stratulat T; Bussolino F; Righi L; Novello S; Scagliotti GV; Riganti C
    Int J Cancer; 2020 Jan; 146(1):192-207. PubMed ID: 31107974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calretinin promotes invasiveness and EMT in malignant mesothelioma cells involving the activation of the FAK signaling pathway.
    Wörthmüller J; Blum W; Pecze L; Salicio V; Schwaller B
    Oncotarget; 2018 Nov; 9(91):36256-36272. PubMed ID: 30555628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
    Ma X; Wang B; Wang X; Luo Y; Fan W
    PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin.
    Ries A; Flehberger D; Slany A; Pirker C; Mader JC; Mohr T; Schelch K; Sinn K; Mosleh B; Hoda MA; Dome B; Dolznig H; Krupitza G; Müllauer L; Gerner C; Berger W; Grusch M
    J Exp Clin Cancer Res; 2023 Jan; 42(1):27. PubMed ID: 36683050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin-ATP-binding cassette G2 signaling.
    Chau WK; Ip CK; Mak AS; Lai HC; Wong AS
    Oncogene; 2013 May; 32(22):2767-81. PubMed ID: 22797058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing GOLPH3 gene expression reverses resistance to cisplatin in HT29 colon cancer cells via multiple signaling pathways.
    Zhou ZP; Wang LP; Hong ZS; Qiu CZ; Wang MZ; Chen ZX; Tang LF; Yu WS; Wang CX
    Int J Oncol; 2018 Sep; 53(3):1183-1192. PubMed ID: 30015866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SHCBP1 promotes cisplatin induced apoptosis resistance, migration and invasion through activating Wnt pathway.
    Zou A; Wu A; Luo M; Zhou C; Lu Y; Yu X
    Life Sci; 2019 Oct; 235():116798. PubMed ID: 31472149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.